Search

Fisher & Paykel Healthcare Corp Ltd

Abierto

SectorInmobiliario

32.6 -0.03

Resumen

Variación precio

24h

Actual

Mínimo

32.2

Máximo

32.72

Métricas clave

By Trading Economics

Ingresos

-37M

187M

Ventas

-316M

965M

P/B

Media del Sector

51.406

74.384

Rentabilidad por dividendo

1.31

Margen de beneficios

19.353

Empleados

7,384

EBITDA

-335M

319M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+13.12% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.31%

6.04%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-5.9M

19B

Apertura anterior

32.63

Cierre anterior

32.6

Fisher & Paykel Healthcare Corp Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 nov 2025, 21:31 UTC

Charlas de Mercado

F&P Healthcare's Share Price Jumps on Profit Guidance Upgrade -- Market Talk

29 jun 2025, 22:48 UTC

Charlas de Mercado

Export Data Buoy Fisher & Paykel Healthcare Bull -- Market Talk

28 may 2025, 22:28 UTC

Charlas de Mercado

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 abr 2025, 02:01 UTC

Charlas de Mercado

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 feb 2025, 21:55 UTC

Charlas de Mercado

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 feb 2025, 22:06 UTC

Charlas de Mercado

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

Fisher & Paykel Healthcare Corp Ltd previsión

Precio Objetivo

By TipRanks

13.12% repunte

Estimación a 12 Meses

Media 37.093 AUD  13.12%

Máximo 42.8 AUD

Mínimo 31 AUD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fisher & Paykel Healthcare Corp Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

4

Comprar

3

Mantener

1

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.